Industry Research Reports

Home > Reports > Medical Care > Global Infectious Disease Clinical Trials Market Insights, Forecast to 2030

Global Infectious Disease Clinical Trials Market Insights, Forecast to 2030

Industry: Medical Care

Published Date: 2024-04-12

Pages: 94 Pages

Report ld: 2920344

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Market Analysis and Insights: Global Infectious Disease Clinical Trials Market

The global Infectious Disease Clinical Trials market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Infectious Disease Clinical Trials is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Infectious Disease Clinical Trials is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for Infectious Disease Clinical Trials is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key companies of Infectious Disease Clinical Trials include IQVIA, LabCorp, Charles River, WuXi AppTec, Syneos Health, PPD and ICON Plc, etc. In 2023, the global top five players had a share approximately % in terms of revenue.

Infectious Disease Clinical Trials is widely used in various fields, such as Vaccines, Cell & Gene Therapy and Others,, etc. Vaccines provides greatest supports to the Infectious Disease Clinical Trials industry development. In 2023, global % revenue of Infectious Disease Clinical Trials went into Vaccines filed and the proportion will reach to % in 2030.

Report Covers:

This report presents an overview of global market for Infectious Disease Clinical Trials market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Infectious Disease Clinical Trials, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Infectious Disease Clinical Trials, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Infectious Disease Clinical Trials revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Infectious Disease Clinical Trials market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Infectious Disease Clinical Trials revenue, projected growth trends, production technology, application and end-user industry.

MARKET SEGMENTATION

By Company

IQVIA
LabCorp
Charles River
WuXi AppTec
Syneos Health
PPD
ICON Plc

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Phase I
Phase II
Phase III
Phase IV

Segment by Application

Vaccines
Cell & Gene Therapy
Others

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Infectious Disease Clinical Trials Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Phase I

1.2.3 Phase II

1.2.4 Phase III

1.2.5 Phase IV

1.3 Market by Application

1.3.1 Global Infectious Disease Clinical Trials Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Vaccines

1.3.3 Cell & Gene Therapy

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Infectious Disease Clinical Trials Market Perspective (2019-2030)

2.2 Global Infectious Disease Clinical Trials Growth Trends by Region

2.2.1 Infectious Disease Clinical Trials Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Infectious Disease Clinical Trials Historic Market Size by Region (2019-2024)

2.2.3 Infectious Disease Clinical Trials Forecasted Market Size by Region (2025-2030)

2.3 Infectious Disease Clinical Trials Market Dynamics

2.3.1 Infectious Disease Clinical Trials Industry Trends

2.3.2 Infectious Disease Clinical Trials Market Drivers

2.3.3 Infectious Disease Clinical Trials Market Challenges

2.3.4 Infectious Disease Clinical Trials Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Infectious Disease Clinical Trials by Players

3.1.1 Global Infectious Disease Clinical Trials Revenue by Players (2019-2024)

3.1.2 Global Infectious Disease Clinical Trials Revenue Market Share by Players (2019-2024)

3.2 Global Infectious Disease Clinical Trials Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Infectious Disease Clinical Trials, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Infectious Disease Clinical Trials Market Concentration Ratio

3.4.1 Global Infectious Disease Clinical Trials Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Infectious Disease Clinical Trials Revenue in 2023

3.5 Global Key Players of Infectious Disease Clinical Trials Head office and Area Served

3.6 Global Key Players of Infectious Disease Clinical Trials, Product and Application

3.7 Global Key Players of Infectious Disease Clinical Trials, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Infectious Disease Clinical Trials Breakdown Data by Type

4.1 Global Infectious Disease Clinical Trials Historic Market Size by Type (2019-2024)

4.2 Global Infectious Disease Clinical Trials Forecasted Market Size by Type (2025-2030)

5 Infectious Disease Clinical Trials Breakdown Data by Application

5.1 Global Infectious Disease Clinical Trials Historic Market Size by Application (2019-2024)

5.2 Global Infectious Disease Clinical Trials Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Infectious Disease Clinical Trials Market Size (2019-2030)

6.2 North America Infectious Disease Clinical Trials Market Size by Type

6.2.1 North America Infectious Disease Clinical Trials Market Size by Type (2019-2024)

6.2.2 North America Infectious Disease Clinical Trials Market Size by Type (2025-2030)

6.2.3 North America Infectious Disease Clinical Trials Market Share by Type (2019-2030)

6.3 North America Infectious Disease Clinical Trials Market Size by Application

6.3.1 North America Infectious Disease Clinical Trials Market Size by Application (2019-2024)

6.3.2 North America Infectious Disease Clinical Trials Market Size by Application (2025-2030)

6.3.3 North America Infectious Disease Clinical Trials Market Share by Application (2019-2030)

6.4 North America Infectious Disease Clinical Trials Market Size by Country

6.4.1 North America Infectious Disease Clinical Trials Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Infectious Disease Clinical Trials Market Size by Country (2019-2024)

6.4.3 North America Infectious Disease Clinical Trials Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Infectious Disease Clinical Trials Market Size (2019-2030)

7.2 Europe Infectious Disease Clinical Trials Market Size by Type

7.2.1 Europe Infectious Disease Clinical Trials Market Size by Type (2019-2024)

7.2.2 Europe Infectious Disease Clinical Trials Market Size by Type (2025-2030)

7.2.3 Europe Infectious Disease Clinical Trials Market Share by Type (2019-2030)

7.3 Europe Infectious Disease Clinical Trials Market Size by Application

7.3.1 Europe Infectious Disease Clinical Trials Market Size by Application (2019-2024)

7.3.2 Europe Infectious Disease Clinical Trials Market Size by Application (2025-2030)

7.3.3 Europe Infectious Disease Clinical Trials Market Share by Application (2019-2030)

7.4 Europe Infectious Disease Clinical Trials Market Size by Country

7.4.1 Europe Infectious Disease Clinical Trials Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Infectious Disease Clinical Trials Market Size by Country (2019-2024)

7.4.3 Europe Infectious Disease Clinical Trials Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Infectious Disease Clinical Trials Market Size (2019-2030)

8.2 China Infectious Disease Clinical Trials Market Size by Type

8.2.1 China Infectious Disease Clinical Trials Market Size by Type (2019-2024)

8.2.2 China Infectious Disease Clinical Trials Market Size by Type (2025-2030)

8.2.3 China Infectious Disease Clinical Trials Market Share by Type (2019-2030)

8.3 China Infectious Disease Clinical Trials Market Size by Application

8.3.1 China Infectious Disease Clinical Trials Market Size by Application (2019-2024)

8.3.2 China Infectious Disease Clinical Trials Market Size by Application (2025-2030)

8.3.3 China Infectious Disease Clinical Trials Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Infectious Disease Clinical Trials Market Size (2019-2030)

9.2 Asia Infectious Disease Clinical Trials Market Size by Type

9.2.1 Asia Infectious Disease Clinical Trials Market Size by Type (2019-2024)

9.2.2 Asia Infectious Disease Clinical Trials Market Size by Type (2025-2030)

9.2.3 Asia Infectious Disease Clinical Trials Market Share by Type (2019-2030)

9.3 Asia Infectious Disease Clinical Trials Market Size by Application

9.3.1 Asia Infectious Disease Clinical Trials Market Size by Application (2019-2024)

9.3.2 Asia Infectious Disease Clinical Trials Market Size by Application (2025-2030)

9.3.3 Asia Infectious Disease Clinical Trials Market Share by Application (2019-2030)

9.4 Asia Infectious Disease Clinical Trials Market Size by Region

9.4.1 Asia Infectious Disease Clinical Trials Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Infectious Disease Clinical Trials Market Size by Region (2019-2024)

9.4.3 Asia Infectious Disease Clinical Trials Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Infectious Disease Clinical Trials Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Infectious Disease Clinical Trials Market Size by Type

10.2.1 Middle East, Africa, and Latin America Infectious Disease Clinical Trials Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Infectious Disease Clinical Trials Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Infectious Disease Clinical Trials Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Infectious Disease Clinical Trials Market Size by Application

10.3.1 Middle East, Africa, and Latin America Infectious Disease Clinical Trials Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Infectious Disease Clinical Trials Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Infectious Disease Clinical Trials Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Infectious Disease Clinical Trials Market Size by Country

10.4.1 Middle East, Africa, and Latin America Infectious Disease Clinical Trials Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Infectious Disease Clinical Trials Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Infectious Disease Clinical Trials Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 IQVIA

11.1.1 IQVIA Company Details

11.1.2 IQVIA Business Overview

11.1.3 IQVIA Infectious Disease Clinical Trials Introduction

11.1.4 IQVIA Revenue in Infectious Disease Clinical Trials Business (2019-2024)

11.1.5 IQVIA Recent Developments

11.2 LabCorp

11.2.1 LabCorp Company Details

11.2.2 LabCorp Business Overview

11.2.3 LabCorp Infectious Disease Clinical Trials Introduction

11.2.4 LabCorp Revenue in Infectious Disease Clinical Trials Business (2019-2024)

11.2.5 LabCorp Recent Developments

11.3 Charles River

11.3.1 Charles River Company Details

11.3.2 Charles River Business Overview

11.3.3 Charles River Infectious Disease Clinical Trials Introduction

11.3.4 Charles River Revenue in Infectious Disease Clinical Trials Business (2019-2024)

11.3.5 Charles River Recent Developments

11.4 WuXi AppTec

11.4.1 WuXi AppTec Company Details

11.4.2 WuXi AppTec Business Overview

11.4.3 WuXi AppTec Infectious Disease Clinical Trials Introduction

11.4.4 WuXi AppTec Revenue in Infectious Disease Clinical Trials Business (2019-2024)

11.4.5 WuXi AppTec Recent Developments

11.5 Syneos Health

11.5.1 Syneos Health Company Details

11.5.2 Syneos Health Business Overview

11.5.3 Syneos Health Infectious Disease Clinical Trials Introduction

11.5.4 Syneos Health Revenue in Infectious Disease Clinical Trials Business (2019-2024)

11.5.5 Syneos Health Recent Developments

11.6 PPD

11.6.1 PPD Company Details

11.6.2 PPD Business Overview

11.6.3 PPD Infectious Disease Clinical Trials Introduction

11.6.4 PPD Revenue in Infectious Disease Clinical Trials Business (2019-2024)

11.6.5 PPD Recent Developments

11.7 ICON Plc

11.7.1 ICON Plc Company Details

11.7.2 ICON Plc Business Overview

11.7.3 ICON Plc Infectious Disease Clinical Trials Introduction

11.7.4 ICON Plc Revenue in Infectious Disease Clinical Trials Business (2019-2024)

11.7.5 ICON Plc Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

TABLE OF FIGURES

List of Tables

Table 1. Global Infectious Disease Clinical Trials Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Phase I

Table 3. Key Players of Phase II

Table 4. Key Players of Phase III

Table 5. Key Players of Phase IV

Table 6. Global Infectious Disease Clinical Trials Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 7. Global Infectious Disease Clinical Trials Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Infectious Disease Clinical Trials Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Infectious Disease Clinical Trials Market Share by Region (2019-2024)

Table 10. Global Infectious Disease Clinical Trials Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Infectious Disease Clinical Trials Market Share by Region (2025-2030)

Table 12. Infectious Disease Clinical Trials Market Trends

Table 13. Infectious Disease Clinical Trials Market Drivers

Table 14. Infectious Disease Clinical Trials Market Challenges

Table 15. Infectious Disease Clinical Trials Market Restraints

Table 16. Global Infectious Disease Clinical Trials Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Infectious Disease Clinical Trials Revenue Share by Players (2019-2024)

Table 18. Global Top Infectious Disease Clinical Trials by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease Clinical Trials as of 2023)

Table 19. Global Infectious Disease Clinical Trials Industry Ranking 2022 VS 2023 VS 2024

Table 20. Global 5 Largest Players Market Share by Infectious Disease Clinical Trials Revenue (CR5 and HHI) & (2019-2024)

Table 21. Global Key Players of Infectious Disease Clinical Trials, Headquarters and Area Served

Table 22. Global Key Players of Infectious Disease Clinical Trials, Product and Application

Table 23. Global Key Players of Infectious Disease Clinical Trials, Product and Application

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Infectious Disease Clinical Trials Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Infectious Disease Clinical Trials Revenue Market Share by Type (2019-2024)

Table 27. Global Infectious Disease Clinical Trials Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Infectious Disease Clinical Trials Revenue Market Share by Type (2025-2030)

Table 29. Global Infectious Disease Clinical Trials Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Infectious Disease Clinical Trials Revenue Share by Application (2019-2024)

Table 31. Global Infectious Disease Clinical Trials Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Infectious Disease Clinical Trials Revenue Share by Application (2025-2030)

Table 33. North America Infectious Disease Clinical Trials Market Size by Type (2019-2024) & (US$ Million)

Table 34. North America Infectious Disease Clinical Trials Market Size by Type (2025-2030) & (US$ Million)

Table 35. North America Infectious Disease Clinical Trials Market Size by Application (2019-2024) & (US$ Million)

Table 36. North America Infectious Disease Clinical Trials Market Size by Application (2025-2030) & (US$ Million)

Table 37. North America Infectious Disease Clinical Trials Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. North America Infectious Disease Clinical Trials Market Size by Country (2019-2024) & (US$ Million)

Table 39. North America Infectious Disease Clinical Trials Market Size by Country (2025-2030) & (US$ Million)

Table 40. Europe Infectious Disease Clinical Trials Market Size by Type (2019-2024) & (US$ Million)

Table 41. Europe Infectious Disease Clinical Trials Market Size by Type (2025-2030) & (US$ Million)

Table 42. Europe Infectious Disease Clinical Trials Market Size by Application (2019-2024) & (US$ Million)

Table 43. Europe Infectious Disease Clinical Trials Market Size by Application (2025-2030) & (US$ Million)

Table 44. Europe Infectious Disease Clinical Trials Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Europe Infectious Disease Clinical Trials Market Size by Country (2019-2024) & (US$ Million)

Table 46. Europe Infectious Disease Clinical Trials Market Size by Country (2025-2030) & (US$ Million)

Table 47. China Infectious Disease Clinical Trials Market Size by Type (2019-2024) & (US$ Million)

Table 48. China Infectious Disease Clinical Trials Market Size by Type (2025-2030) & (US$ Million)

Table 49. China Infectious Disease Clinical Trials Market Size by Application (2019-2024) & (US$ Million)

Table 50. China Infectious Disease Clinical Trials Market Size by Application (2025-2030) & (US$ Million)

Table 51. Asia Infectious Disease Clinical Trials Market Size by Type (2019-2024) & (US$ Million)

Table 52. Asia Infectious Disease Clinical Trials Market Size by Type (2025-2030) & (US$ Million)

Table 53. Asia Infectious Disease Clinical Trials Market Size by Application (2019-2024) & (US$ Million)

Table 54. Asia Infectious Disease Clinical Trials Market Size by Application (2025-2030) & (US$ Million)

Table 55. Asia Infectious Disease Clinical Trials Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 56. Asia Infectious Disease Clinical Trials Market Size by Region (2019-2024) & (US$ Million)

Table 57. Asia Infectious Disease Clinical Trials Market Size by Region (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Infectious Disease Clinical Trials Market Size by Type (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Infectious Disease Clinical Trials Market Size by Type (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Infectious Disease Clinical Trials Market Size by Application (2019-2024) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Infectious Disease Clinical Trials Market Size by Application (2025-2030) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Infectious Disease Clinical Trials Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 63. Middle East, Africa, and Latin America Infectious Disease Clinical Trials Market Size by Country (2019-2024) & (US$ Million)

Table 64. Middle East, Africa, and Latin America Infectious Disease Clinical Trials Market Size by Country (2025-2030) & (US$ Million)

Table 65. IQVIA Company Details

Table 66. IQVIA Business Overview

Table 67. IQVIA Infectious Disease Clinical Trials Product

Table 68. IQVIA Revenue in Infectious Disease Clinical Trials Business (2019-2024) & (US$ Million)

Table 69. IQVIA Recent Developments

Table 70. LabCorp Company Details

Table 71. LabCorp Business Overview

Table 72. LabCorp Infectious Disease Clinical Trials Product

Table 73. LabCorp Revenue in Infectious Disease Clinical Trials Business (2019-2024) & (US$ Million)

Table 74. LabCorp Recent Developments

Table 75. Charles River Company Details

Table 76. Charles River Business Overview

Table 77. Charles River Infectious Disease Clinical Trials Product

Table 78. Charles River Revenue in Infectious Disease Clinical Trials Business (2019-2024) & (US$ Million)

Table 79. Charles River Recent Developments

Table 80. WuXi AppTec Company Details

Table 81. WuXi AppTec Business Overview

Table 82. WuXi AppTec Infectious Disease Clinical Trials Product

Table 83. WuXi AppTec Revenue in Infectious Disease Clinical Trials Business (2019-2024) & (US$ Million)

Table 84. WuXi AppTec Recent Developments

Table 85. Syneos Health Company Details

Table 86. Syneos Health Business Overview

Table 87. Syneos Health Infectious Disease Clinical Trials Product

Table 88. Syneos Health Revenue in Infectious Disease Clinical Trials Business (2019-2024) & (US$ Million)

Table 89. Syneos Health Recent Developments

Table 90. PPD Company Details

Table 91. PPD Business Overview

Table 92. PPD Infectious Disease Clinical Trials Product

Table 93. PPD Revenue in Infectious Disease Clinical Trials Business (2019-2024) & (US$ Million)

Table 94. PPD Recent Developments

Table 95. ICON Plc Company Details

Table 96. ICON Plc Business Overview

Table 97. ICON Plc Infectious Disease Clinical Trials Product

Table 98. ICON Plc Revenue in Infectious Disease Clinical Trials Business (2019-2024) & (US$ Million)

Table 99. ICON Plc Recent Developments

Table 100. Research Programs/Design for This Report

Table 101. Key Data Information from Secondary Sources

Table 102. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Infectious Disease Clinical Trials Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Infectious Disease Clinical Trials Market Share by Type: 2023 VS 2030

Figure 3. Phase I Features

Figure 4. Phase II Features

Figure 5. Phase III Features

Figure 6. Phase IV Features

Figure 7. Global Infectious Disease Clinical Trials Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 8. Global Infectious Disease Clinical Trials Market Share by Application: 2023 VS 2030

Figure 9. Vaccines Case Studies

Figure 10. Cell & Gene Therapy Case Studies

Figure 11. Others Case Studies

Figure 12. Infectious Disease Clinical Trials Report Years Considered

Figure 13. Global Infectious Disease Clinical Trials Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Infectious Disease Clinical Trials Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Infectious Disease Clinical Trials Market Share by Region: 2023 VS 2030

Figure 16. Global Infectious Disease Clinical Trials Market Share by Players in 2023

Figure 17. Global Top Infectious Disease Clinical Trials Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease Clinical Trials as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Infectious Disease Clinical Trials Revenue in 2023

Figure 19. North America Infectious Disease Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Infectious Disease Clinical Trials Market Share by Type (2019-2030)

Figure 21. North America Infectious Disease Clinical Trials Market Share by Application (2019-2030)

Figure 22. North America Infectious Disease Clinical Trials Market Share by Country (2019-2030)

Figure 23. United States Infectious Disease Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Canada Infectious Disease Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Infectious Disease Clinical Trials Market Size YoY (2019-2030) & (US$ Million)

Figure 26. Europe Infectious Disease Clinical Trials Market Share by Type (2019-2030)

Figure 27. Europe Infectious Disease Clinical Trials Market Share by Application (2019-2030)

Figure 28. Europe Infectious Disease Clinical Trials Market Share by Country (2019-2030)

Figure 29. Germany Infectious Disease Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. France Infectious Disease Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. U.K. Infectious Disease Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Italy Infectious Disease Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Russia Infectious Disease Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Nordic Countries Infectious Disease Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. China Infectious Disease Clinical Trials Market Size YoY (2019-2030) & (US$ Million)

Figure 36. China Infectious Disease Clinical Trials Market Share by Type (2019-2030)

Figure 37. China Infectious Disease Clinical Trials Market Share by Application (2019-2030)

Figure 38. Asia Infectious Disease Clinical Trials Market Size YoY (2019-2030) & (US$ Million)

Figure 39. Asia Infectious Disease Clinical Trials Market Share by Type (2019-2030)

Figure 40. Asia Infectious Disease Clinical Trials Market Share by Application (2019-2030)

Figure 41. Asia Infectious Disease Clinical Trials Market Share by Region (2019-2030)

Figure 42. Japan Infectious Disease Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. South Korea Infectious Disease Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. China Taiwan Infectious Disease Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Southeast Asia Infectious Disease Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. India Infectious Disease Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Australia Infectious Disease Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America Infectious Disease Clinical Trials Market Size YoY (2019-2030) & (US$ Million)

Figure 49. Middle East, Africa, and Latin America Infectious Disease Clinical Trials Market Share by Type (2019-2030)

Figure 50. Middle East, Africa, and Latin America Infectious Disease Clinical Trials Market Share by Application (2019-2030)

Figure 51. Middle East, Africa, and Latin America Infectious Disease Clinical Trials Market Share by Country (2019-2030)

Figure 52. Brazil Infectious Disease Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Mexico Infectious Disease Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Turkey Infectious Disease Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Saudi Arabia Infectious Disease Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Israel Infectious Disease Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. GCC Countries Infectious Disease Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. IQVIA Revenue Growth Rate in Infectious Disease Clinical Trials Business (2019-2024)

Figure 59. LabCorp Revenue Growth Rate in Infectious Disease Clinical Trials Business (2019-2024)

Figure 60. Charles River Revenue Growth Rate in Infectious Disease Clinical Trials Business (2019-2024)

Figure 61. WuXi AppTec Revenue Growth Rate in Infectious Disease Clinical Trials Business (2019-2024)

Figure 62. Syneos Health Revenue Growth Rate in Infectious Disease Clinical Trials Business (2019-2024)

Figure 63. PPD Revenue Growth Rate in Infectious Disease Clinical Trials Business (2019-2024)

Figure 64. ICON Plc Revenue Growth Rate in Infectious Disease Clinical Trials Business (2019-2024)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Infectious Disease Clinical Trials market? zhanKai

The top companies in the global Infectious Disease Clinical Trials market are IQVIA、LabCorp、Charles River.

Related Reports

Global Infectious Disease Clinical Trials Market Research Report 2025
The global market for Infectious Disease Clinical Trials was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-01
Pages: 80
USD 2900.00
(Single User License)
Global Infectious Disease Clinical Trials Market Research Report 2024
The global Infectious Disease Clinical Trials market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-12
Pages: 76
USD 2900.00
(Single User License)
Infectious Disease Clinical Trials - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Infectious Disease Clinical Trials was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-08
Pages: 85
USD 3950.00
(Single User License)

Global Infectious Disease Clinical Trials Market Research Report 2025
The global market for Infectious Disease Clinical Trials was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-01
Pages: 80
USD 2900.00 (Single User License)
Global Infectious Disease Clinical Trials Market Research Report 2024
The global Infectious Disease Clinical Trials market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-12
Pages: 76
USD 2900.00 (Single User License)
Infectious Disease Clinical Trials - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Infectious Disease Clinical Trials was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-08
Pages: 85
USD 3950.00 (Single User License)